Sort
48,018 grants matching “immunotherapy”
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
$398,925Scripps Research Institute · R01 · FY2001 · CA
Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AML
$398,922Jeffrey S Miller · University Of Minnesota · P01 · FY2023 · CA
The B7x pathways in the tumor microenvironment
$398,901Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
TARGETED EPIGENETIC MODIFICATION TO IMPROVE MESOTHELIOMA RESPONSES TO IMMUNOTHERAPY
$398,881University Of Western Australia · · FY2020 · Defense Health Agency
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE
$398,880University Of Michigan At Ann Arbor · R01 · FY2002 · DA
Highly stable mini-circRNA vaccine with maximally activated and long-lasting T cells for HPV-related cancer combination immunotherapy
$398,823Gordon Parry · Ampedrna Biosciences Llc · R43 · FY2024 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$398,803David J Mooney · Harvard University · R01 · FY2018 · CA
Targeting Syk to enhance anti-tumor immune responses in neuroblastoma
$398,787Shweta Joshi · University Of California, San Diego · R01 · FY2022 · NS
Targeting Syk to enhance anti-tumor immune responses in neuroblastoma
$398,787Shweta Joshi · University Of California, San Diego · R01 · FY2021 · NS
Targeting Syk to enhance anti-tumor immune responses in neuroblastoma
$398,787Shweta Joshi · University Of California, San Diego · R01 · FY2025 · NS
Targeting Syk to enhance anti-tumor immune responses in neuroblastoma
$398,787Shweta Joshi · University Of California, San Diego · R01 · FY2023 · NS
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$398,775Scott Andrew Gerber · University Of Rochester · R01 · FY2019 · CA
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
$398,767Yan Xu · Indiana University Indianapolis · R01 · FY2014 · CA
ENHANCING IMMUNOTHERAPY BY TRIGGERING FERROPTOSIS
$398,755Duke University · · FY2021 · Defense Health Agency
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
$398,750Ashish A. Kulkarni · University Of Massachusetts Amherst · R35 · FY2023 · GM
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
$398,750Ashish A. Kulkarni · University Of Massachusetts Amherst · R35 · FY2024 · GM
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
$398,750Ashish A. Kulkarni · University Of Massachusetts Amherst · R35 · FY2025 · GM
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
$398,750Ashish A. Kulkarni · University Of Massachusetts Amherst · R35 · FY2022 · GM
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$398,717Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$398,698Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI
GENE EXPRESSION PROFILE OF PROGRESSION &RESPONSE IN CML
$398,689Fred Hutchinson Cancer Research Center · U01 · FY2003 · CA
Network-driven drug repurposing in cardiovascular disease: NDRA clinical trial planning
$398,689Chiara Giannarelli · New York University School Of Medicine · U34 · FY2021 · TR
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
$398,683Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2020 · CA
Designing Antibody Drug Conjugates for Durable and Complete Therapeutic Responses
$398,642Greg Thurber · University Of Michigan At Ann Arbor · R35 · FY2024 · GM
Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer
$398,591Kamiya Mehla · University Of Oklahoma Hlth Sciences Ctr · R37 · FY2023 · CA